#Canada #Toronto #Wound Care #MolecuLight #DocNow

Enhancing Wound Management: The New Integration of MolecuLight and DocNow

In a groundbreaking collaboration, MolecuLight Inc. and DocNow have announced an innovative integration aimed at refining clinical workflows within wound management. MolecuLight, renowned for its cutting-edge fluorescence imaging, has partnered with DocNow, a leader in post-acute Electronic Health Records (EHR), to enhance the capabilities of the MolecuLightDX™ device.

This integration not only streamlines data and image transfer between MolecuLight and DocNow, but also serves a vital role in improving patient documentation in post-acute facilities. By connecting seamlessly with systems like PointClickCare and MatrixCare, this unified approach supports uninterrupted service for mobile wound care providers even when offline, a critical feature for those consistently on the move.

Key Features of the Integration

1. Automatic Data Transfer: Clinicians benefit from a direct Wi-Fi enabled upload of both standard and bacterial autofluorescence images from the MolecuLightDX device straight into the DocNow EHR system, ensuring that important information is always at their fingertips.
2. Comprehensive Wound Documentation: Wound specifics, including critical measurements such as tunneling and undermining, are automatically recorded, feeding into a thorough patient history for enhanced care.
3. Offline Functionality: This integration is especially designed for mobile practitioners, allowing them to document care in real-time without relying on a stable internet connection.
4. Patient Census Integration: The ability to seamlessly incorporate this imaging technology into the 'patient census' scheduling workflow within DocNow allows for a cohesive approach to patient management.
5. Robust Documentation Support: The integration with PointClickCare and MatrixCare facilitates comprehensive and accurate documentation in various post-acute environments.

Statements from Leadership

Anil Amlani, CEO of MolecuLight, expressed excitement about this strategic partnership, highlighting the importance of immediate access to actionable insights at the point of care. He noted, "Our validated FDA-cleared Class II device equips clinicians with crucial information regarding bacterial presence and facilitates precise digital wound measurement, improving patient outcomes across diverse healthcare settings."

Likewise, Dr. Lauren Neuman, Chief Clinical Officer at DocNow, emphasized the integration’s potential to revolutionize patient care. "Integrating MolecuLight's advanced imaging technology with our EHR platform empowers clinicians to visualize bacterial presence in real time, fostering informed wound care decisions at the moment of treatment."

About MolecuLight and DocNow

MolecuLight Inc. stands at the forefront of medical imaging, offering unique solutions for wound care through its FDA-cleared imaging devices. The MolecuLight iX® and DX™ are specifically crafted to detect elevated bacterial burdens in wounds while allowing for meticulous digital measurements.

Conversely, DocNow provides an unprecedented EHR and virtual care platform tailored for post-acute providers, enhancing clinical, administrative, and documentation operations within skilled nursing facilities and home health settings.

As this collaboration unfolds, it promises to deliver a substantial leap forward in the field of wound care, showcasing the synergy of cutting-edge technology in improving patient outcomes and care efficiency.

Conclusion

The integration of MolecuLight and DocNow sets a new standard in wound management, demonstrating how innovative technology can lead to improved clinical workflows. As healthcare continues to evolve, partnerships like these will be pivotal in ensuring better patient care, driving progress in post-acute environments, and streamlining the challenges faced by today's healthcare providers.